DE3781400D1 - Arzneimittel zur behandlung von augenentzuendung. - Google Patents

Arzneimittel zur behandlung von augenentzuendung.

Info

Publication number
DE3781400D1
DE3781400D1 DE8787301743T DE3781400T DE3781400D1 DE 3781400 D1 DE3781400 D1 DE 3781400D1 DE 8787301743 T DE8787301743 T DE 8787301743T DE 3781400 T DE3781400 T DE 3781400T DE 3781400 D1 DE3781400 D1 DE 3781400D1
Authority
DE
Germany
Prior art keywords
medicines
treating eye
eye inflammation
oacyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787301743T
Other languages
English (en)
Other versions
DE3781400T2 (de
Inventor
John J Boltralik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Priority claimed from EP87301743A external-priority patent/EP0280797B1/de
Application granted granted Critical
Publication of DE3781400D1 publication Critical patent/DE3781400D1/de
Publication of DE3781400T2 publication Critical patent/DE3781400T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19873781400 1987-02-27 1987-02-27 Arzneimittel zur behandlung von augenentzuendung. Expired - Lifetime DE3781400T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87301743A EP0280797B1 (de) 1985-10-30 1987-02-27 Arzneimittel zur Behandlung von Augenentzündung

Publications (2)

Publication Number Publication Date
DE3781400D1 true DE3781400D1 (de) 1992-10-01
DE3781400T2 DE3781400T2 (de) 1992-12-10

Family

ID=8197802

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19873781400 Expired - Lifetime DE3781400T2 (de) 1987-02-27 1987-02-27 Arzneimittel zur behandlung von augenentzuendung.
DE1997175036 Active DE19775036I2 (de) 1987-02-27 1987-02-27 Arzneimittel zur Behandlung von Augenentzündung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1997175036 Active DE19775036I2 (de) 1987-02-27 1987-02-27 Arzneimittel zur Behandlung von Augenentzündung.

Country Status (2)

Country Link
AT (1) ATE79756T1 (de)
DE (2) DE3781400T2 (de)

Also Published As

Publication number Publication date
DE3781400T2 (de) 1992-12-10
ATE79756T1 (de) 1992-09-15
DE19775036I2 (de) 2009-11-05

Similar Documents

Publication Publication Date Title
ATE19733T1 (de) Hydroxysubstituierte benzothiazolsulfonamide fuer die topische behandlung von intraokularer hypertension.
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
ATE153855T1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
PT561073E (pt) Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
ATE42895T1 (de) Steroide als immunomodulierende mittel.
AU528287B2 (en) Improvements relating to the treatment of flat glass
YU117185A (en) Process for obtaining 2-substituted-1,3 propyl of idenediphosphonate derivatives
AU526270B2 (en) Acid addition salt of 2beta,16beta diperidino 5 alpha androstane derivatives
AU3369584A (en) Tetra hydro thiopyran -3-yl - cyclohexenone derivatives
NO970340L (no) Organiske forbindelser
BG50389A3 (en) A process for the production of delta 1,4-3-keto c21-semiester sieroids
DE3781400D1 (de) Arzneimittel zur behandlung von augenentzuendung.
DK529585D0 (da) N-(6-methoxy-5-(perflouralkyl)-1-naphtholyl)-n-methylglyciner og deres thionaphthoyl analoge, deres fremstilling og anvendelse som laegemidler
AU1616676A (en) Stable aqueous colloidal solutions of fluorescent'whitening agents
SE7908994L (sv) Tiazolidin- och pyrrolidinderivat
EP0655457A4 (de)
DE3852526D1 (de) Neue pharmazeutische Präparate sowie neue Lactosylverbindungen und ihre Herstellung.
ES2026485T3 (es) Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas.
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
TW332205B (en) A process for making a clinically efficacious HIV protease inhibitor eliminates one step in its synthesis, by an alternative convergent synthesis using 2(S)-4-picolyl-2-piperazine-t-butyl-carboxamide as an intermediate.
DE69129623D1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: RIMEXOLON ENTHALTENDE AUGENTROPFEN (VEXOL 1%); REGISTRATION NO/DATE: 38846.00.00, 19970124

Spc suppl protection certif: 197 75 036

Filing date: 19970717

V472 Application for supplementary protection certificate rejected

Free format text: PRODUCT NAME: RIMEXOLON ENTHALTENDE AUGENTROPFEN (VEXOL 1%); REGISTRATION NO/DATE: 38846.00.00, 19970124

Spc suppl protection certif: 197 75 036

Filing date: 19970717